Objective: To estimate the prevalence of childhood ataxia resulting from both genetic and acquired causes.
ataxia is estimated by systematically examining prevalence estimates for the many different causes of childhood ataxia. METHODS Search strategy. A systematic review of the literature was undertaken in consultation with a clinical informationist from Johns Hopkins School of Medicine. The review process was based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement. 13 The 5 databases searched from the earliest record to April 2, 2012, were PubMed, Web of Science, EMBASE, CINHAL, and Scopus. The search terms (see appendix e-1 on the Neurology ® Web site at www. neurology.org) included keywords and controlled vocabulary, if applicable, with 3 concepts being searched: 1) ataxia, 2) measurement of disease frequency (e.g., prevalence, incidence), and 3) childhood. No restrictions were placed on the language or publication date.
Data extraction. Following the literature search, duplicate abstracts were removed using a research management tool (Ref-Works, Bethesda, MD). All abstracts were then independently reviewed by 2 authors (K.E.M. and R.M.) to select articles warranting full review. To be selected for full review, the article must have 1) reported on an ataxia-causing condition, 2) included, or been suspected of including, children in the sample, and 3) included, or been suspected of including, some measure of the frequency of ataxia, such as the number of cases, prevalence, incidence, frequency, or percentage of the sample that showed ataxia.
Full paper reviews, which were performed by one author (K.E.M.), first involved determining whether the paper met any exclusion criteria, as follows: 1) conference abstracts, 2) review articles, if the review did not provide an original estimate of disease frequency, 3) articles in which the pediatric and adult data could not be separated, and 4) articles in which the data concerning ataxia could not be separated from data involving another neurologic condition. Reference lists were scanned and relevant references reviewed. To ensure that only articles on ataxia-causing conditions were included, a third author (M.E.J.) independently confirmed the diseases and conditions associated with ataxia. 14, 15 The following information was extracted from included articles: location, time period, method(s) used to identify cases, method(s) used to confirm diagnoses, age range of cases, number of pediatric cases identified, size of the pediatric population, and measure of frequency (e.g., prevalence, incidence, or percentage showing ataxia) with 95% confidence interval (CI). In the case of transient causes of ataxia, we also attempted to record the average length of time that ataxia was experienced. The majority of included articles were in English, but some were in French, Spanish, German, Portuguese, Croatian, Turkish, Japanese, Icelandic, Danish, and Chinese. For these papers individuals proficient in the relevant language assisted with translation.
Lastly, risk of bias (i.e., the risk that the study over-or underestimated the true prevalence) was assessed. We adopted a domain-based evaluation, in which the likelihood of bias was assessed for different aspects of study design. 16, 17 The following domains were evaluated. 18 
Sampling bias was evaluated by how representative the cases
were of the intended target population. 2. Measurement bias was evaluated by the method used to identify ataxia or the ataxia-causing condition. 3. Bias in analysis was evaluated by the inclusion of CIs for estimates of prevalence and incidence.
Included articles were given risk ratings of "low," "high," or "unclear" for each of the above 3 domains. 17 Data analysis. Included articles were classified according to the 6 geographical regions outlined by the WHO (Africa, Americas, Southeast Asia, Europe, Eastern Mediterranean, and Western Pacific) and then further divided according to etiology of ataxiagenetic, acquired, or mixed. Mixed ataxias included conditions believed to be multifactorial in etiology, with both genetics and environment having a role. Examples of mixed ataxias include ataxic cerebral palsy 19 and pediatric multiple sclerosis. 20 In the genetic category, autosomal recessive cerebellar ataxias were further categorized into the following 4 groupings: degenerative and progressive ataxias, DNA repair defects, metabolic ataxias, and congenital ataxias. 21 We used point prevalence (total cases/population at a single point in time) and period prevalence (total cases/population over a specified period of time) as the measures of frequency. For articles that reported incidence or an incidence rate, those measures were converted to prevalence in 1 of 2 ways.
1. Prevalence 5 incidence if: a) the condition is present from the time of birth, b) the condition cannot be cured, and c) life expectancy with the condition exceeds childhood. Conditions that met these criteria included many of the hereditary ataxias and other childhood-long conditions, such as congenital malformations. 2. Prevalence 5 incidence 3 duration of ataxia 22 if the ataxia was transient in nature or if the average life expectancy with the condition was shortened such that affected children typically do not reach adulthood. Often an estimate of duration could not be found; thus, we could not calculate prevalence from incidence in these cases.
Some articles did not report prevalence or incidence but instead reported the percentage of the sample that showed ataxia. If the incidence or prevalence of the ataxia-causing condition (e.g., cerebral palsy) could be found for the same geographical region, either in the same article or from another source, then the prevalence of the condition with ataxia could be calculated.
A few articles reported only the number of pediatric cases of an ataxia-causing condition. If the size of the pediatric population in the same geographical location at roughly the same time could be found, prevalence was calculated by dividing the number of pediatric cases by the total pediatric population.
Prevalence estimates are reported with a 95% CI. If the CI was not reported in the article, it was calculated using the Jeffreys method 23 whenever possible. Prevalence estimates for genetic, acquired, and mixed ataxias were displayed in forest plots. Only prevalence values with a similar denominator (i.e., rate/100,000 children aged ;0-19 years) were included in the plots. Since the methods used to identify and diagnose cases of childhood ataxia varied greatly across articles, it was not possible to combine data across articles as is done in a meta-analysis. Furthermore, the scarcity of prevalence data available for all WHO regions except Europe limited the analysis. For the European region we reported the median and range of prevalence estimates for each ataxiacausing condition and summed the median values to gauge the total prevalence of childhood ataxia in Europe.
RESULTS
The results from the search and screening are outlined in figure 1. The search returned almost 6,000 abstracts, and of the 355 articles reviewed in full, 115 were included. A summary of the included articles, as well as an assessment of each study's risk of bias, can be found in appendix e-2. The likelihood of bias varied with WHO region, with the European studies being the least susceptible to bias on average. Likewise, we found childhood ataxia-the causes, reporting, and prevalence-to vary considerably by region.
Europe. The most represented WHO region in the data was Europe; 52% of the included studies were conducted in European countries (figure 2). More than 80% of the European articles were from Western Europe. While few articles had publication dates prior to 1990, prevalence dates and periods covered many decades. Data were found for all 4 categories of autosomal recessive cerebellar ataxia. 21 One article reported the prevalence of autosomal dominant cerebellar ataxia in children. 11 Sixteen articles looked at the frequency of ataxic cerebral palsy. Data were also available for Rett syndrome, hemophagocytic lymphohistiocytosis, Dandy-Walker syndrome, cerebellar hypoplasia, intracerebral hemorrhage, celiac disease, pediatric multiple sclerosis, varicella, tickborne encephalitis, acute disseminated encephalomyelitis, sclerosing panencephalitis secondary to measles, the measles-mumps-rubella vaccine, tumors, and ataxia caused by epilepsy medication.
In Europe, population-based studies were the norm; typically researchers sought to identify all cases by accessing numerous resources or relying on nationwide registries or screening programs. Mandatory newborn screening programs exist in several European countries, and there are also some far-reaching organizations for surveillance of neurologic disorders; thus, there was a wealth of population-based data on the incidence of various ataxias. Often ataxia was identified through a neurologic exam by a physician; however, sometimes its presence was inferred through medical records or questionnaires, which increased the likelihood of bias. Most studies reported a CI for the estimate of frequency or the data needed to calculate the interval.
Americas. The Americas accounted for ;23% of included articles, with more than half coming from the United States ( figure 2 ). There was a variety of prevalence dates and periods ). Data, albeit sparse compared with Europe, were found for all but one category of autosomal recessive cerebellar ataxia-the congenital ataxias. 21 The prevalence of autosomal dominant cerebellar ataxia in children was reported for Holguín, Cuba; however, this area has the highest prevalence of spinocerebellar ataxias in the world, 9 so its prevalence is not representative of the rest of the Americas. The prevalence of autosomal recessive spastic ataxia of Charlevoix-Saguenay and of Leigh syndrome was reported for children in regions of Quebec, Canada, where there is a much higher prevalence of both diseases compared with the rest of the world, due to consanguinity. 24, 25 Only 2 studies, also from Quebec, reported on the frequency of ataxic cerebral palsy. 26, 27 There were also data for Kawasaki disease, alternating hemiplegia of childhood, and basilar-type migraine. There were 5 to 6 articles found each for drug-induced ataxias (side effect or poisoning) and tumors. The frequency of drug-induced ataxia varied with the drug; prevalence estimates for the drug-induced ataxias were not provided. Likewise, the number of children experiencing ataxia as result of a tumor varied with the location of the tumor. Data were also found for acute disseminated encephalomyelitis, bacterial neonatal meningitis, and varicella. Samples of convenience were frequently used in the studies from the Americas, for example, reports of calls to poison control centers or retrospective chart reviews. Thus, the risk of sampling bias was high. The risk of measurement bias was more variable, with some studies conducted prospectively and requiring neurologic exams (smaller likelihood of bias) and others relying on retrospective review of medical records (greater likelihood of bias). A CI surrounding the prevalence/frequency estimate was reported or calculated for most articles; thus, the bias related to analysis was low.
Western Pacific. In the Western Pacific region, Australia and Japan were the most represented countries, followed by China. Prevalence periods spanned from 1970 to 2008. Data were found for the prevalence of several metabolic ataxias; however, these were the only autosomal recessive ataxias studied. Data were also found on ataxic cerebral palsy, Rett syndrome, alternating hemiplegia of childhood, hemophagocytic lymphohistiocytosis, basilar-type migraine, varicella, meningitis, and ataxia resulting from petrol sniffing.
The risk of bias varied across studies. Some studies used robust sampling methods, such as national registries, whereas others relied on samples of convenience. Likewise, ataxia may have been identified through direct contact and evaluation of the cases or through retrospective chart review. CIs were calculated for most studies; thus, the risk of bias with respect to analysis was low.
Eastern Mediterranean. In the Eastern Mediterranean region, 9 articles were included and covered Saudi Arabia, Egypt, Iran, Libya, and Jordan. Prevalence periods were relatively recent, with the earliest reported year being 1985. Friedreich ataxia and ataxia telangiectasia were the only autosomal recessive ataxias for which prevalence estimates were reported. Data were also found for Dandy-Walker syndrome, ataxic cerebral palsy, and pediatric multiple sclerosis.
Overall, the risk of sampling bias was deemed high, as samples of convenience and retrospective reviews of medical records were frequently employed. The risk of bias related to measurement and analysis was lower, as many studies confirmed diagnoses through clinical exams and/or imaging and reported sufficient data to calculate CIs.
Africa. We found data on only 2 ataxia-causing conditions in Africa. Both were acquired ataxias that are somewhat unique to this WHO region. Tropical ataxic neuropathy (TAN) is a polyneuropathy that may result from consumption of cassava, a cyanideproducing food. 10 The prevalence of TAN in several Nigerian communities is extremely high, ;260 to 570/100,000 children aged 10 to 19 years. 8, 10 These prevalence estimates were obtained by meticulous case finding and diagnosis in the community (e.g., door-to-door screening of the entire local population and follow-up neurologic exams for all suspected cases). 8, 10 Thus, the risk of bias was deemed low.
Data were also found for malaria-induced ataxia. Malaria is very prevalent in children in some areas of Africa. For example, a prevalence of 49,000/ 100,000 children has been reported. 28 A small percentage of children with malaria experience ataxia (0.2%-2.8%). [29] [30] [31] The studies concerning malaria involved samples of convenience, so the risk of sampling bias was high. Two of the 3 articles, however, used WHO criteria for the diagnosis of malaria and neurologic exams to identify ataxia; thus, the risk of measurement bias was deemed more favorable. CIs could be calculated for all data from Africa.
Southeast Asia. The least amount of data came from Southeast Asia. Only 3 studies, all conducted in India, were included from this WHO region. The articles reported on leukodystrophy, 32 somatoform disorders, 33 and acute disseminated encephalomyelitis. 34 All involved samples of convenience. Thus the risk of sampling bias was high, yet the risk of bias from measurement and analysis was considered low.
Prevalence of genetic, acquired, and mixed ataxias. Forest plots of the prevalence of genetic, acquired, and mixed ataxias are presented in figures 3-5, respectively. Articles that reported the prevalence over the whole range of childhood (i.e., rate per 100,000 children aged ;0 to 19 years) are represented in the plots. For example, the prevalence of TAN, which was reported as rate per 100,000 children aged 10 to 19 years, was not included.
Overall prevalence of childhood ataxia in Europe. To gauge the overall prevalence of ataxia in children, data from Europe were used. Data from this region were chosen since they 1) covered the greatest number of ataxia-causing conditions, 2) reported prevalence estimates, as opposed to simply a percentage, and 3) were deemed the least susceptible to bias of all the WHO regions. The overall prevalence of ataxia was estimated to be ;26/100,000 children, with genetic and mixed ataxias combined accounting for most of that figure (table) . DISCUSSION Here we show that childhood ataxia is more common than might be interpreted based on isolated studies of specific ataxia-causing conditions. Our estimate of the prevalence of childhood ataxia is 26/100,000 children. While childhood ataxia is rare relative to childhood conditions like cerebral palsy (211/100,000 children) 35 and autism spectrum disorders (620/100,000 children), 36 it is more prevalent than conditions like hereditary spastic paraparesis (3.8/100,000). 11 Our prevalence estimate is based on data from Europe, which has a comprehensive pediatric health care system. Knowing that a similar system is not necessarily found in the other WHO regions, the true worldwide prevalence of childhood ataxia is likely higher.
Regional differences. The causes of ataxia varied by WHO region due to regional differences in genetic background, environmental risks, public health policies, and resources. Estimates of genetic conditions were higher in countries with known consanguinity. For example, the prevalence of early-onset cerebellar ataxia with retained tendon reflexes was lower in northwestern Italy (0.97/100,000 children) 7 compared with the Al-Kharga District in Egypt (3.92/ 100,000 children). 12 Ataxias attributable to environmental causes also varied by region. TAN 8, 10 and ataxia as a complication of malaria [29] [30] [31] were only reported from Africa. We speculate that public health policies led to some differences between regions. For example, the prevalence of ataxia secondary to varicella will depend on a country's requirements for varicella vaccination. Finally, data from newborn screening programs were only available from more developed countries, possibly reflecting differences in resources available for tracking human health.
Strengths and limitations of review. Estimating the prevalence of ataxia, which is characterized by such a large and heterogeneous group of etiologies, is challenging. The first strength of this review is that it identifies gaps in our current knowledge about the prevalence of childhood ataxia and highlights areas in need of research. Second, we collected all available data from all WHO regions. Identifying regional differences in the prevalence and causes of childhood ataxia will guide future region-specific work. Third, this review can serve as a model for future studies investigating the epidemiology of a clinical disorder that has a number of varied etiologies. Finally, we would like to note that without initiatives to systematically record the presence of ataxia regardless of etiology, a well-designed systematic review is the most effective method for obtaining this information in a timely and cost-effective manner.
There are a few limitations of our review to note. First, there is considerable variability in the type and quality of data from different WHO regions, which limits the generalizability of our findings. We did not include regional search engines, hence many of the articles came from European or North American journals. This may have limited the number of articles from non-Western countries. Furthermore, we were unable find data on all the different ataxiacausing conditions. For example, prevalence estimates for ataxia with oculomotor apraxia were not retrieved from any WHO region. Second, we did not discriminate between the methods used to confirm the presence of ataxia, as we wanted to err on the side of inclusiveness. The likelihood of bias may have been less had we excluded studies that ascertained cases through questionnaires or chart reviews. Third, we included conditions that cause ataxia in most cases; however, it is possible that some of the cases included in a prevalence estimate did not experience ataxia. Finally, we did not exclude any articles based on the prevalence period, so our review spans ;60 to 70 years. The prevalence of some conditions may change over time, although the prevalence of cerebral palsy, the most common single cause of childhood ataxia, has been stable since at least the 1980s. 35 Likewise, diagnostic methods change over time, and older methods may not be as sensitive, reliable, or accurate as current methods, resulting in changing prevalence estimates across time. 11 The likelihood of bias may have been reduced by limiting our review to studies with recent prevalence periods; however, this would have significantly reduced the amount of data included. It is also noteworthy that classification systems and names of conditions change over time, both of which may have made the data difficult to interpret. For example, as disease-causing genes are identified, nonspecific terms like early-onset cerebellar ataxia with retained tendon reflexes are used less frequently.
Recommendations for the future. This review suggests that childhood ataxia is not an insignificant problem and that it is experienced across the globe. Our findings also suggest a number of shortcomings concerning the study of childhood ataxia and lead to the following recommendations. First, regional and global initiatives are needed to undertake epidemiologic studies of ataxia in children. Data from less developed regions are especially needed. Such initiatives exist for other childhood conditions, such as the International Autism Epidemiology Network. 36 Second, standard criteria for the diagnosis of ataxia should be established. This will facilitate the aggregation and comparison of data across studies and geographical regions. Third, more research concerning the measurement and treatment of childhood ataxia is needed. There are few reports specific to children regarding the measurement 37 and treatment of ataxia (pharmacologic [38] [39] [40] [41] [42] and nonpharmacologic [43] [44] [45] ). This may reflect the fact that the overall prevalence and importance of childhood ataxia has likely been underestimated in the past, despite the fact that ataxia is associated with significant economic cost and decreased quality of life. 46 We hope the findings of this review increase awareness of childhood ataxia and motivate further study on this serious childhood affliction.
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